GTS Securities’s Franklin Genomic Advancements ETF HELX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-27,603
| Closed | -$874K | – | 1906 |
|
|
2024
Q2 | $874K | Buy |
27,603
+13,899
| +101% | +$440K | ﹤0.01% | 689 |
|
|
2024
Q1 | $449K | Sell |
13,704
-35,228
| -72% | -$1.15M | ﹤0.01% | 847 |
|
|
2023
Q4 | $1.49M | Buy |
+48,932
| New | +$1.49M | ﹤0.01% | 474 |
|
|
2023
Q3 | – | Sell |
-44,781
| Closed | -$1.35M | – | 1629 |
|
|
2023
Q2 | $1.35M | Buy |
+44,781
| New | +$1.35M | 0.04% | 352 |
|